Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Regor Pharmaceuticals Inc.
Cogent Biosciences, Inc.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Unity Health Toronto
Second Life Therapeutics
Beaumont Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
University of Sunderland
Universidade Federal de Pernambuco
Danatlas Pharmaceuticals Co., Ltd
NovaOnco Therapeutics Co., Ltd.
Sun Yat-sen University
Convalife (Shanghai) Co., Ltd.